How large is the arthrogryposis market, and what is its growth trajectory?
The arthrogryposis market size has grown strongly in recent years. It will grow from $0.93 billion in 2024 to $0.98 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to the increasing prevalence of osteoarthritis, rising incidences of sports injuries, rising aging population, rising sedentary lifestyle, and increasing awareness about osteoarthritis therapeutics.
The arthrogryposis market size is expected to see strong growth in the next few years. It will grow to $1.22 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to the growing geriatric population, increasing adoption of pain medications, rising number of sports injuries, increasing prevalence of osteoarthritis, and growing population susceptible to osteoarthritis. Major trends in the forecast period include advancements in medical technology, innovations in genetic research, technological advancements in treatment options, the development of non-surgical treatments, and advancements in biologics and stem cell therapies.
Get Your Free Sample of The Global Arthrogryposis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21105&type=smp
What are the key forces behind the arthrogryposis market’s growth in recent years?
The rising prevalence of congenital disorders is expected to propel the growth of the arthrogryposis market going forward. Congenital disorders are abnormalities, either structural or functional, that occur during fetal development and are present at birth. The increasing prevalence of congenital disorders can be attributed to factors such as advances in prenatal diagnostics, environmental exposures, genetic mutations, and lifestyle changes. Arthrogryposis helps in understanding congenital disorders by highlighting the role of fetal movement, genetic factors, and neuromuscular development in musculoskeletal abnormalities. For instance, in February 2023, according to the World Health Organization, a Switzerland-based intergovernmental organization, each year, approximately 240,000 newborns globally succumb to congenital disorders within the first 28 days of life. Additionally, congenital conditions contribute to an estimated 170,000 child fatalities between the ages of 1 month and 5 years. Therefore, the rising prevalence of congenital disorders is driving growth in the arthrogryposis market.
Impact Of Rising Telehealth Services On The Growth Of The Market
The rise in telehealth services is expected to propel the growth of the arthrogryposis market going forward. Telehealth services refer to the use of digital communication tools, such as video calls, phone calls, and online messaging, to provide healthcare services and consultations remotely, making it easier for patients to access medical care from home or other locations. Telehealth services are increasing due to their convenience, accessibility, and ability to reduce healthcare costs while improving patient access to care, especially in remote or underserved areas. Arthrogryposis benefits telehealth services by enabling remote consultations, early diagnosis, and continuous management of joint contractures, improving access to specialized care for patients with mobility challenges. For instance, in May 2024, according to the Australian Digital Health Agency, an Australia-based government organization, over 95,000 practitioners had utilized telehealth services, and 118.2 million telehealth services were offered to 18 million patients over the last two years. Therefore, the rise in telehealth services is driving growth in the arthrogryposis market.
What are the major segments of the arthrogryposis market?
The arthrogryposis market covered in this report is segmented –
1) By Type: Classic Arthrogryposis, Distal Arthrogryposis, Amyoplasia
2) By Treatment Type: Occupational Therapists, Physical Therapy, Surgery, Imaging Diagnostics, CT Scan
3) By Patient Age: Children, Adults, Elderly
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
Subsegments:
1) By Classic Arthrogryposis: Multiple Joint Involvement, Flexion Contractures, Severe Muscle Weakness, Progressive Arthrogryposis, Intellectual Impairment
2) By Distal Arthrogryposis: Isolated Limb Involvement, Contractures of Hands and Feet, Distal Joint Contractures, Autosomal Dominant Inheritance
3) By Amyoplasia: Severe Limb Contractures, Muscle Hypotonia (low muscle tone), No Cognitive Impairment, Symmetric Joint Involvement, Lack Of Muscle Development In Affected Limbs
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/arthrogryposis-global-market-report
Which companies dominate the arthrogryposis market?
Major companies operating in the arthrogryposis market are Hitachi Ltd., The Cleveland Clinic Foundation, The Johns Hopkins Health System Corporation, NYU Langone Hospitals, Seattle Children’s Hospital, Boston Children’s Hospital, Phoenix Children’s Hospital Inc., Children’s Healthcare of Atlanta Inc., The Nemours Foundation, Shriners Hospitals for Children, Hanger Inc., Texas Scottish Rite Hospital for Children, Gillette Children’s Specialty Healthcare, Paley Orthopedic & Spine Institute LLC, Quantum Rehab a division of Pride Mobility Products Corp., Obi Robot Inc., Gammie HomeCare LLC, Prothotic Laboratories Inc., SSM Health Cardinal Glennon Children’s Hospital, Arthrogryposis Multiplex Congenita Support Inc.
What major trends will shape the arthrogryposis market during the forecast period?
Major companies operating in the arthrogryposis market are focusing on advancements in surgical techniques such as carpal wedge osteotomy to improve joint mobility and reduce contractures, offering patients better functional outcomes and enhancing their quality of life. Carpal wedge osteotomy is a surgical procedure that involves removing a wedge-shaped section of bone from the wrist to correct joint deformities and improve hand function in patients with conditions like arthrogryposis. For instance, in November 2022, Akron Children’s Hospital, a US-based pediatric acute care hospital, developed a new procedure that combines carpal wedge osteotomy and flexor-pronator slide, aiming to enhance joint mobility for patients suffering from this rare condition characterized by stiff or contracted joints.
What are the key regional dynamics of the arthrogryposis market, and which region leads in market share?
North America was the largest region in the arthrogryposis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arthrogryposis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Arthrogryposis Market Report 2025 Offer?
The arthrogryposis market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Arthrogryposis refers to a group of congenital conditions characterized by multiple joint contractures, leading to stiffness and limited movement. It occurs due to reduced fetal movement in the womb, which can result from neurological, muscular, or connective tissue disorders.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21105
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
